Downregulating sphingosine kinase-1 for cancer therapy

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.8, 2008-08, pp. : 1009-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting

Current Molecular Pharmacology, Vol. 3, Iss. 2, 2010-01 ,pp. : 53-65

Bentham Science Publishers

Access to resources Recommend Favorite

PIM1 kinase as a target for cancer therapy

By Merkel Anna Lena Meggers Eric Ocker Matthias

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 425-436

Informa Healthcare

Access to resources Recommend Favorite

The Expression of Sphingosine Kinase-1 in Head and Neck Carcinoma

Cells Tissues Organs, Vol. 192, Iss. 5, 2010-07 ,pp. : 314-324

Karger

Access to resources Recommend Favorite

Stratification of Sphingosine Kinase-1 Expression and Activity in Rat Kidney

Cells Tissues Organs, Vol. 188, Iss. 4, 2008-06 ,pp. : 384-392

Karger

Access to resources Recommend Favorite

Altering the Sphingosine-1-Phosphate/Ceramide Balance: A Promising Approach for Tumor Therapy

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4625-4635

Bentham Science Publishers

Access to resources Recommend Favorite